Hyaluronic acid (intraarticular)

Jump to: navigation, search
Hyaluronic acid (intraarticular)
Adult Indications & Dosage
Pediatric Indications & Dosage
Contraindications
Warnings & Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Administration & Monitoring
Overdosage
Pharmacology
Clinical Studies
How Supplied
Images
Patient Counseling Information
Precautions with Alcohol
Brand Names
Look-Alike Names

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Disclaimer

WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.

Overview

Hyaluronic acid (intraarticular) is a cartilaginous defect repair agent that is FDA approved for the treatment of osteoarthritis of knee. Common adverse reactions include injection site pain, injection site reaction, arthralgia.

Adult Indications and Dosage

FDA-Labeled Indications and Dosage (Adult)

For the treatment of Osteoarthritis of knee

Off-Label Use and Dosage (Adult)

Guideline-Supported Use

There is limited information regarding Off-Label Guideline-Supported Use of Hyaluronic acid (intraarticular) in adult patients.

Non–Guideline-Supported Use

There is limited information regarding Off-Label Non–Guideline-Supported Use of Hyaluronic acid (intraarticular) in adult patients.

Pediatric Indications and Dosage

FDA-Labeled Indications and Dosage (Pediatric)

There is limited information regarding FDA-Labeled Use of Hyaluronic acid (intraarticular) in pediatric patients.

Off-Label Use and Dosage (Pediatric)

Guideline-Supported Use

There is limited information regarding Off-Label Guideline-Supported Use of Hyaluronic acid (intraarticular) in pediatric patients.

Non–Guideline-Supported Use

There is limited information regarding Off-Label Non–Guideline-Supported Use of Hyaluronic acid (intraarticular) in pediatric patients.

Contraindications

There is limited information regarding Hyaluronic acid (intraarticular) Contraindications in the drug label.

Warnings

There is limited information regarding Hyaluronic acid (intraarticular) Warnings' in the drug label.

Adverse Reactions

Clinical Trials Experience

There is limited information regarding Clinical Trial Experience of Hyaluronic acid (intraarticular) in the drug label.

Postmarketing Experience

There is limited information regarding Postmarketing Experience of Hyaluronic acid (intraarticular) in the drug label.

Drug Interactions

There is limited information regarding Hyaluronic acid (intraarticular) Drug Interactions in the drug label.

Use in Specific Populations

Pregnancy

Pregnancy Category (FDA): There is no FDA guidance on usage of Hyaluronic acid (intraarticular) in women who are pregnant.
Pregnancy Category (AUS): There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Hyaluronic acid (intraarticular) in women who are pregnant.

Labor and Delivery

There is no FDA guidance on use of Hyaluronic acid (intraarticular) during labor and delivery.

Nursing Mothers

There is no FDA guidance on the use of Hyaluronic acid (intraarticular) with respect to nursing mothers.

Pediatric Use

There is no FDA guidance on the use of Hyaluronic acid (intraarticular) with respect to pediatric patients.

Geriatic Use

There is no FDA guidance on the use of Hyaluronic acid (intraarticular) with respect to geriatric patients.

Gender

There is no FDA guidance on the use of Hyaluronic acid (intraarticular) with respect to specific gender populations.

Race

There is no FDA guidance on the use of Hyaluronic acid (intraarticular) with respect to specific racial populations.

Renal Impairment

There is no FDA guidance on the use of Hyaluronic acid (intraarticular) in patients with renal impairment.

Hepatic Impairment

There is no FDA guidance on the use of Hyaluronic acid (intraarticular) in patients with hepatic impairment.

Females of Reproductive Potential and Males

There is no FDA guidance on the use of Hyaluronic acid (intraarticular) in women of reproductive potentials and males.

Immunocompromised Patients

There is no FDA guidance one the use of Hyaluronic acid (intraarticular) in patients who are immunocompromised.

Administration and Monitoring

Administration

  • Intraarticular

Monitoring

There is limited information regarding Monitoring of Hyaluronic acid (intraarticular) in the drug label.

IV Compatibility

There is limited information regarding IV Compatibility of Hyaluronic acid (intraarticular) in the drug label.

Overdosage

There is limited information regarding Chronic Overdose of Hyaluronic acid (intraarticular) in the drug label.

Pharmacology

Template:Chembox E numberTemplate:Chembox SolubilityInWaterTemplate:Chembox Lethal amounts (set)
Hyaluronic acid (intraarticular)
Identifiers
ChemSpider
ECHA InfoCard Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value). Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value).
UNII
Properties
(C14H21NO11)n
Hazards
S-phrases S22, S24/25 (sodium salt)
Related compounds
Except where noted otherwise, data are given for
materials in their standard state
(at 25 °C, 100 kPa)

Infobox disclaimer and references

Mechanism of Action

There is limited information regarding Hyaluronic acid (intraarticular) Mechanism of Action in the drug label.

Structure

There is limited information regarding Hyaluronic acid (intraarticular) Structure in the drug label.

Pharmacodynamics

There is limited information regarding Pharmacodynamics of Hyaluronic acid (intraarticular) in the drug label.

Pharmacokinetics

There is limited information regarding Pharmacokinetics of Hyaluronic acid (intraarticular) in the drug label.

Nonclinical Toxicology

There is limited information regarding Nonclinical Toxicology of Hyaluronic acid (intraarticular) in the drug label.

Clinical Studies

There is limited information regarding Clinical Studies of Hyaluronic acid (intraarticular) in the drug label.

How Supplied

  • 3mL in a 10mL Single Use Syringe.
  • Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature]. Protect from freezing.

Storage

There is limited information regarding Hyaluronic acid (intraarticular) Storage in the drug label.

Images

Drug Images

Package and Label Display Panel

Hyaluronic acid (intraarticular)03.png
This image of the FDA label is provided by the National Library of Medicine.
Hyaluronic acid (intraarticular)04.png
This image of the FDA label is provided by the National Library of Medicine.

Patient Counseling Information

There is limited information regarding Patient Counseling Information of Hyaluronic acid (intraarticular) in the drug label.

Precautions with Alcohol

Alcohol-Hyaluronic acid (intraarticular) interaction has not been established. Talk to your doctor regarding the effects of taking alcohol with this medication.

Brand Names

There is limited information regarding Hyaluronic acid (intraarticular) Brand Names in the drug label.

Look-Alike Drug Names

There is limited information regarding Hyaluronic acid (intraarticular) Look-Alike Drug Names in the drug label.

Drug Shortage Status

Price

References

The contents of this FDA label are provided by the National Library of Medicine.

  1. Template:ChemID, consulté le 12 février 2009

Linked-in.jpg